Skip to main content

EDITORIAL article

Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1465835
This article is part of the Research Topic Advances in Novel Pharmacotherapeutics and Drug Discovery: Computational, Experimental, Translational, and Clinical Models. View all 12 articles

Editorial: Advances in Novel Pharmacotherapeutics and Drug Discovery: Computational, Experimental, Translational, and Clinical Models

Provisionally accepted
Cristian Sandoval Cristian Sandoval 1,2*Francisco Torrens Francisco Torrens 3Vanessa Souza-Mello Vanessa Souza-Mello 4Jorge G. Farias Jorge G. Farias 2
  • 1 Santo Tomás University, Santiago, Chile
  • 2 University of La Frontera, Temuco, Araucania, Chile
  • 3 University of Valencia, Valencia, Valencian Community, Spain
  • 4 Rio de Janeiro State University, Rio de Janeiro, Rio de Janeiro, Brazil

The final, formatted version of the article will be published soon.

    Keywords: Drug Delivery & Targeting, Publich health, Cancer, QSAR & docking, multidisciplinary approach

    Received: 16 Jul 2024; Accepted: 29 Jul 2024.

    Copyright: © 2024 Sandoval, Torrens, Souza-Mello and Farias. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Cristian Sandoval, Santo Tomás University, Santiago, Chile

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.